Protara Therapeutics Stock (NASDAQ: TARA) stock price, news, charts, stock research, profile.
You can purchase shares of Protara Therapeutics (NASDAQ:TARA) through any online brokerage.
Other companies in Protara Therapeutics’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), Gain Therapeutics (NASDAQ:GANX) and OncoCyte (NASDAQ:OCX).
Protara Therapeutics has a consensus price target of $23.33.
The stock price for Protara Therapeutics (NASDAQ: TARA) is $1.8005 last updated September 24, 2024 at 7:00 PM EDT.
There are no upcoming dividends for Protara Therapeutics.
Protara Therapeutics’s Q3 earnings are confirmed for Friday, November 1, 2024.
There is no upcoming split for Protara Therapeutics.
Protara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.